Seres Therapeutics
MCRB
MCRB
119 hedge funds and large institutions have $743M invested in Seres Therapeutics in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 51 increasing their positions, 28 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
0.26% less ownership
Funds ownership: 4.93% → 4.67% (-0.26%)
3% less funds holding
Funds holding: 123 → 119 (-4)
16% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 25
Holders
119
Holding in Top 10
1
Calls
$2.31M
Puts
$1.31M
Top Buyers
| 1 | +$109M | |
| 2 | +$56.1M | |
| 3 | +$14.6M | |
| 4 |
EP
Eversept Partners
New York
|
+$12.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.22M |
Top Sellers
| 1 | -$9.34M | |
| 2 | -$3.96M | |
| 3 | -$3.75M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$3.26M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.63M |